Clinical Trial Update: Gossypol (AT-101) and Temozolomide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety and dosing of gossypol (AT-101) with temozolomide with or without radiation therapy in newly diagnosed glioblastoma multifor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Gossypol (AT-101) (gossypol)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Brain and Central Nervous System Tumors | Phase 1 | Status: COMPLETED